Pharma Consulting Plays A Crucial Role In Increasing Pharmaceutical Profits

Feb 5th

Pharma Consulting Plays A Crucial Role In Increasing Pharmaceutical Profits

Posted in Advertising
Comments 0

Our healthcare system is extremely complicated, with a lot of moving parts, but is nevertheless one of our most important economic drivers. There are many different incentives and restrictions governing the use of an individual pharmaceutical product and many different agendas along the way. Before a pharmaceutical products can be brought to the market, it faces a difficult road from the desk of a scientist to the hand of the consumer. In the dissemination of information, pharmaceutical consultants help to ensure that all those who have an input into the decision-making process are fully aware of all the repercussions.

A pharmaceutical company faces many challenges, quite apart from the manufacture of its products. As a pharmaceutical consulting firm stresses, the company owes the consumer in general a debt of revelation. Pharmaceutical companies regularly operate on the sharp end of discovery and their revelations may be truly ground-breaking. Without an adequate marketing channel, these findings might never make their way via the regulators to the front-line professionals. Those with a financial interest, especially the all important insurers, will also benefit from a good marketing approach, as they will be made aware of the positive features and benefits associated.

While regulators will ultimately determine if a pharmaceutical product may be made available and will confirm the associated claims, the pharmaceutical company must be able to market itself, its reputation and its products within the ultra-competitive and distracted healthcare industry. It should be noted that certain principals within the industry have an incentive to steer healthcare practitioners and their patients toward older, or generic medications and that these agendas may not be in the best interests of the sufferer. Pharmaceutical companies have a clear incentive to trumpet the benefits of their wares in such a noisy marketplace and help to create a dynamic and forward thinking mindset.

It is unfortunate that the ultimate care of the patient is very often not the ultimate goal of certain vested interests. In popular opinion, healthcare reform is always controversial and the pharmaceutical company would do well to accurately and forcefully communicate its position. The harried physician must listen to many different interested parties before a decision can be made about the patient, including the views of other professionals, training and education, patient restrictions, formularies, best practices and traditions. Statistics tell us that 90% of the most frequently prescribed drugs are generics and thus it is difficult for pharmaceutical companies to ensure that they are being heard in the right place at the right time. In most cases, pharma consulting firms are used to this difficult environment and can certainly help to open channels and engage practices.

Pharmaceutical companies have been responsible for many of the most amazing discoveries in the world of medicine. Previous generations would surely marvel at some of the cures available today. Much emphasis must be put on marketing “the word” to ensure that our health care continues to improve.

Alan Gillies is the Director of L2L Consulting, an elite pharmaceutical consultancy firm which specialises in Strategy Development and Implementation Excellence for prestigious multi-national organisations.